FIGURE
Fig. 6
- ID
- ZDB-FIG-190724-19
- Publication
- Seda et al., 2019 - An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 6
Dose-response of leflunomide treatment. Representative images in ventral view at 5 days post-fertilization showing effects of indicated doses of leflunomide treatment from 50% epiboly. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Mol. Syndromol.